G. Wallenstein
Impact in
-
- Migraine and Headache Studies
-
- Inhalation and Respiratory Drug Delivery
- Lung Cancer Treatments and Mutations
- Chronic Obstructive Pulmonary Disease (COPD) Research
Papers in
-
- Statistical Methods in Clinical Trials 3
-
- Lung Cancer Treatments and Mutations 2
- Chronic Obstructive Pulmonary Disease (COPD) Research 1
- Co-authors
- Thomas S. Meyer (1 shared paper)Wolfgang Timmer (1 shared paper)Peter Brand (1 shared paper)G. Scheuch (1 shared paper)Bernard Zinman (1 shared paper)Kim Cocks (1 shared paper)Ingolf Griebsch (1 shared paper)Joanne van Ryn (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)Diabetologia (1 paper)Cephalalgia (1 paper)Pharmaceutical Research (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
G. Wallenstein
13 papers receiving 343 citations
Peers
Comparison fields: 5 of 53
- Psychiatry and Mental health 80
- Pulmonary and Respiratory Medicine 99
- Statistics and Probability 37
- Endocrinology, Diabetes and Metabolism 31
- Pharmacology 23
Countries citing papers authored by G. Wallenstein
This map shows the geographic impact of G. Wallenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Wallenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Wallenstein more than expected).
Fields of papers citing papers by G. Wallenstein
This network shows the impact of papers produced by G. Wallenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Wallenstein. The network helps show where G. Wallenstein may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Wallenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 77 | |
| 2 | 2013 | 48 | |
| 3 | 2020 | 48 | |
| 4 | 2004 | 43 | |
| 5 | 2007 | 41 | |
| 6 | 2021 | 41 | |
| 7 | 2014 | 18 | |
| 8 | 2016 | 18 | |
| 9 | 2013 | 16 | |
| 10 | 2017 | 5 | |
| 11 | 1999 | 3 | |
| 12 | 2002 | 3 | |
| 13 | 2017 | 2 | |
| 14 | 2002 | 0 |
About G. Wallenstein
G. Wallenstein is a scholar working on Statistics and Probability, Pulmonary and Respiratory Medicine, Pharmacology, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 14 papers that have together received 363 indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (3 papers), Lung Cancer Treatments and Mutations (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Allergic Rhinitis and Sensitization (1 paper), Inflammatory mediators and NSAID effects (1 paper), Chronic Obstructive Pulmonary Disease (COPD) Research (1 paper) and Migraine and Headache Studies (1 paper). The work is most often cited by research in Psychiatry and Mental health (80 citations), Pulmonary and Respiratory Medicine (99 citations), Statistics and Probability (37 citations), Endocrinology, Diabetes and Metabolism (31 citations) and Pharmacology (23 citations). G. Wallenstein has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Thomas S. Meyer, Wolfgang Timmer, Peter Brand, G. Scheuch, Bernard Zinman, Kim Cocks, Ingolf Griebsch, Joanne van Ryn, Jolien Janssen and Peter C. Trask. Their work appears in journals such as The Journal of Clinical Pharmacology, Cancer Chemotherapy and Pharmacology, Diabetologia, Cephalalgia and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.